The trans-spliceosome, a colossal molecular machine essential to trypanosomatid parasites, was visualized at near-atomic resolution, according to a study published in Nature Communications. This breakthrough, led by researchers at the University of Liège and Rockefeller University, elucidates a mechanism that has eluded scientists for nearly four decades. The machine, responsible for spliced leader (SL) RNA trans-splicing, is a key process in the maturation of messenger RNA (mRNA) in these parasites, which cause tropical diseases affecting millions globally.
The Trans-Spliceosome’s Role in Parasite Survival
Trypanosomatids, which include pathogens like leishmaniasis, sleeping sickness and Chagas disease, rely on the trans-spliceosome to attach a short RNA sequence called SL RNA to the 5′ end of their mRNAs. This step is critical for RNA maturation and cellular function, yet it does not occur in humans. This mechanism is absolutely essential for the parasite's survival and does not exist in this form in humans,
explained Arnaud Vanden Broeck, a biologist heading the Laboratory of RNA Structural Biology and Biochemistry at the University of Liège. Blocking this process could neutralize the parasite without harming human cells, offering a potential target for new therapies.
The study identified two key stages of the trans-spliceosome’s activity: the initial attachment of SL RNA to pre-mRNA and the subsequent formation of mature mRNA. These stages, captured using cryogenic electron microscopy (cryo-EM), revealed the machine’s core structure, the positioning of RNAs during the reaction, and the roles of parasite-specific proteins absent in human cells. Despite some similarities with the splicing machinery found in our own cells, the trans-spliceosome has numerous distinctive adaptations,
Vanden Broeck noted.
Cryo-EM Reveals Molecular Mechanisms
Cryo-EM allowed scientists to obtain high-resolution snapshots of the trans-spliceosome in action. By freezing molecules rapidly and reconstructing their 3D structures from hundreds of thousands of images, researchers observed the machine’s dynamics. The study’s authors described the process as a true molecular factory,
highlighting its complexity and the evolutionary divergence from human splicing mechanisms.
The findings underscore the trans-spliceosome’s ancient origins and its remodeling to perform a different function. These insights advance understanding of eukaryotic evolution and provide a blueprint for designing parasite-specific inhibitors. Beyond advancing our fundamental understanding of the evolution of life, our study provides a concrete basis for designing molecules capable of specifically disrupting this machinery in parasites, whilst sparing human cells,
Vanden Broeck concluded.
Implications for Disease Treatment
The discovery addresses a critical gap in combating trypanosomatid infections, which remain limited by their efficacy, toxicity or the development of resistance. Current treatments for diseases like leishmaniasis, sleeping sickness and Chagas disease are limited, with some causing severe side effects. The trans-spliceosome’s unique structure offers a basis for developing targeted therapies, according to the study. By exploiting differences between parasite and human splicing mechanisms, researchers aim to create drugs that selectively disrupt the parasite’s survival without affecting host cells.
The research also has broader implications for agriculture and livestock. Other trypanosomatids infect livestock, causing major economic losses, while some species infect crops and significantly reduce agricultural yields. Targeting the trans-spliceosome could lead to innovations in managing these infections, reducing both human and agricultural burdens. An encouraging avenue of research in the face of diseases that remain difficult to treat,
Vanden Broeck emphasized.
The study’s publication in Nature Communications marks a milestone in parasitology and structural biology. By revealing the architecture of the trans-spliceosome at near-atomic resolution, the work bridges a long-standing gap in understanding.